|
Real-time Estimate
Tradegate
05:34:35 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 14.16 EUR | -0.65% |
|
-2.58% | +35.73% |
| 09-09 | Leerink Partners Initiates Viatris at Outperform With $20 Price Target | MT |
| 09-08 | Argus Adjusts Price Target on Viatris to $20 From $18, Keeps Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIATRIS INC. | Other Pharmaceuticals | -0.14% | -2.58% | +35.73% | +59.67% | +16.59% | 18.95B |
-
|
-
|
-
|
- Stock Market
- Stocks
- VTRS Stock
- VTRS Stock
- Charts Viatris Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
